Schrenk D, Bignami M, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B
EFSA J. 2020; 18(9):e06223.
PMID: 32994824
PMC: 7507523.
DOI: 10.2903/j.efsa.2020.6223.
Topaktas M, Kafkas N, Sadighazadi S, Istifli E
Cytotechnology. 2017; 69(4):579-589.
PMID: 28097454
PMC: 5507839.
DOI: 10.1007/s10616-017-0069-4.
Erkekoglu P, Zeybek N, Giray B, Rachidi W, Kizilgun M, Hininger-Favier I
Int J Exp Pathol. 2013; 95(1):64-77.
PMID: 24180374
PMC: 3919650.
DOI: 10.1111/iep.12059.
Delille H, Bonekamp N, Schrader M
Int J Biomed Sci. 2013; 2(4):308-14.
PMID: 23674998
PMC: 3614646.
Bunaciu R, Tharappel J, Lehmler H, Lee E, Robertson L, Bruckner G
J Environ Pathol Toxicol Oncol. 2011; 30(4):273-82.
PMID: 22181977
PMC: 3522147.
DOI: 10.1615/jenvironpatholtoxicoloncol.v30.i4.10.
Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity.
Martinez S, Bradford B, Soldatow V, Kosyk O, Sandot A, Witek R
Toxicol Appl Pharmacol. 2010; 249(3):208-16.
PMID: 20869979
PMC: 2980592.
DOI: 10.1016/j.taap.2010.09.012.
Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.
Tsuchiya M, Kono H, Matsuda M, Fujii H, Rusyn I
Int J Cancer. 2008; 123(11):2503-11.
PMID: 18785209
PMC: 2571981.
DOI: 10.1002/ijc.23828.
The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats.
Bunaciu R, Tharappel J, Lehmler H, Kania-Korwel I, Robertson L, Srinivasan C
Toxicology. 2007; 239(3):147-55.
PMID: 17703865
PMC: 2063585.
DOI: 10.1016/j.tox.2007.06.102.
Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.
Woods C, Burns A, Maki A, Bradford B, Cunningham M, Connor H
Free Radic Biol Med. 2007; 42(3):335-42.
PMID: 17210446
PMC: 1829322.
DOI: 10.1016/j.freeradbiomed.2006.10.053.
Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.
Rusyn I, Peters J, Cunningham M
Crit Rev Toxicol. 2006; 36(5):459-79.
PMID: 16954067
PMC: 2614359.
DOI: 10.1080/10408440600779065.
Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?.
Peters J, Cheung C, Gonzalez F
J Mol Med (Berl). 2005; 83(10):774-85.
PMID: 15976920
DOI: 10.1007/s00109-005-0678-9.
Mammalian peroxisomes and reactive oxygen species.
Schrader M, Fahimi H
Histochem Cell Biol. 2004; 122(4):383-93.
PMID: 15241609
DOI: 10.1007/s00418-004-0673-1.
Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.
Boitier E, Gautier J, Roberts R
Comp Hepatol. 2003; 2(1):3.
PMID: 12622871
PMC: 151270.
DOI: 10.1186/1476-5926-2-3.
